We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by
AFT Pharmaceuticals Pty Ltd
I, Rowena Love, as a delegate of the Secretary to the Department of Health and Aged Care, on receipt of an application from AFT Pharmaceuticals Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representation described in paragraph (A), in advertisements for the product identified in paragraph (B).
(A)
- For the temporary relief of pain associated with arthritis/osteoarthritis.
(B)
- MAXIGESIC COLD & FLU HOT DRINK DOUBLE STRENGTH powder for oral liquid sachet (AUST R 360051)
- MAXIGESIC COLD & FLU HOT DRINK powder for oral liquid sachet (AUST R 360050).
Dated this 16th day of September 24
Signed electronically,
Rowena Love
Delegate of the Secretary to the Department of Health and Aged Care
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch